Citadel Advisors
ELOS

Citadel Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Citadel Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,835
Closed -$130K – 8514
2017
Q1 		$125K Buy
11,835
+243
+2% +$2.35K ﹤0.01% 6774
2016
Q4 		$97K Buy
+11,592
New +$90.9K ﹤0.01% 6691
2016
Q1 		– Sell
-14,360
Closed -$111K – 8815
2015
Q4 		$111K Buy
14,360
+6,272
+78% +$47.8K ﹤0.01% 6571
2015
Q3 		$58K Sell
8,088
-94,356
-92% -$907K ﹤0.01% 7473
2015
Q2 		$1.09M Sell
102,444
-81,773
-44% -$958K ﹤0.01% 3854
2015
Q1 		$2.28M Buy
184,217
+127,260
+223% +$1.41M ﹤0.01% 2903
2014
Q4 		$532K Buy
+56,957
New +$549K ﹤0.01% 4649
2014
Q3 		– Sell
-61,381
Closed -$634K – 8643
2014
Q2 		$634K Buy
61,381
+5,477
+10% +$59.2K ﹤0.01% 4093
2014
Q1 		$696K Buy
55,904
+41,932
+300% +$497K ﹤0.01% 3898
2013
Q4 		$171K Sell
13,972
-21,709
-61% -$226K ﹤0.01% 5181
2013
Q3 		$308K Sell
35,681
-67,162
-65% -$580K ﹤0.01% 4320
2013
Q2 		$895K Buy
+102,843
New +$920K ﹤0.01% 3286

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Citadel Advisors's ELOS Position: Q2 2017 in Review

Citadel Advisors sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 11,835 shares — an estimated $130K sold.

Citadel Advisors first reported a position in ELOS in Q2 2013 and held it in 12 quarters. The position peaked at $2.28M in Q1 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Citadel Advisors reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 11,835 Syneron Medical Ltd shares in Q2 2017, an estimated $130K.
  • Citadel Advisors first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 12 quarters.
  • Citadel Advisors's Syneron Medical Ltd position peaked at $2.28M in Q1 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.